Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.
This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.
All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics and antidepressants during pregnancy. We are currently seeking both controls and those being treated with atypical antipsychotics and/ or antidepressants. For more information, please visit this page, call 1-866-961-2388 or e-mail email@example.com.
Course of ADHD in Pregnancy and the Postpartum
If you are less than 20 weeks pregnant and have a history of ADHD, you may be eligible to take part in an observational research study for women maintaining, decreasing, or discontinuing psychostimulants during pregnancy and the postpartum. Women who participate will have 6 study visits that can be completed in-person at Massachusetts General Hospital or over the phone.
For more information, please call (617)726-2912 or email the study coordinator at firstname.lastname@example.org
Are you pregnant or planning a pregnancy? Do you feel depressed or have a history of depression? If you are less than 28 weeks pregnant or trying to conceive and have experienced depression now or in the past, you may be eligible to take part in a research study for the treatment of depression with a prenatal supplement. For more information, please visit this page, call Taylor at 617-643-9284 or email email@example.com
Are you pregnant or planning to become pregnant? Do you have a history of depression? Do you want to lose weight or have a healthier lifestyle? You may be eligible to participate in a research study evaluating a new lifestyle intervention for weight loss. Participants will receive 10 sessions of therapy at no cost to you.
If you are interested in participating or would like additional information, please call Samantha at 617-643-2076.
The MGH Center for Women’s Mental Health
Perinatal and Reproductive Psychiatry Program
Simches Research Building
185 Cambridge St Suite 2200
Boston, MA 02114
To make an appointment:
Massachusetts General Hospital Clinical Program: (617) 724-7792
Location of appointments:
Wang Ambulatory Care Center, Massachusetts General Hospital
15 Parkman St., Floor 8
Boston, MA 02114-3117
March 21, 2018
Fetal Alcohol Spectrum Disorder (FASD) refers to a constellation of disorders resulting from prenatal exposure to alcohol; the manifestations include birth defects, developmental disabilities, and neurological and behavioral problems. Prenatal alcohol exposure is the most common preventable cause of birth defects, and fetal alcohol spectrum disorders are the most commonly identifiable causes of developmental delays ...Read more
March 20, 2018
According to the American Academy of Sleep Medicine, adults should get 7 or more hours of sleep per night in order to avoid the health risks of chronic inadequate sleep. According to a recent study, 35.1% of women aged 40 to 59 years get fewer than the recommended 7 hours of sleep per night. The ...Read more
March 14, 2018
Chasteberry, the fruit of the chaste tree or Vitex agnus castus, has long been touted as a remedy for a range of reproductive problems, including premenstrual symptoms or PMS. Two recent publications have reviewed data on the use of Vitex agnus castus (VAC) for the treatment of premenstrual syndrome and premenstrual dysphoric disorder (PMDD) and ...Read more
March 13, 2018
Many women have concerns about the side effects of hormonal contraceptives, including oral contraceptives, depot preparations, and hormonal IUDs and vaginal rings. Potential side effects include bloating, breast tenderness, and weight gain. In addition, some women may experience depression or mood swings, side effects that may be particularly concerning to women with histories of depression. ...Read more
March 10, 2018
The first publication on the list, from Letourneau and colleagues, is a thorough review of interventions for antenatal and postpartum depression, many of them leading to improvements in parenting and child development. Ruta Nonacs, MD PhD The effect of perinatal depression treatment for mothers on parenting and child development: A systematic review. Letourneau NL, Dennis CL, Cosic ...Read more
March 8, 2018
It is recommended that women with premenstrual symptoms (PMS) switch to a diet including more complex carbohydrates and less sugar in order to alleviate their symptoms. While these dietary modifications may be helpful, a recent study indicates that carbohydrates in the diet is not associated with a woman’s risk of developing PMS symptoms. In this study, researchers ...Read more